Gross Margin

iRhythm's stellar Q2 results are just the start. A major acquisition and a new AI algorithm are set to reshape the cardiac monitoring landscape.

Arlo Technologies smashed expectations with record revenue, fueled by a masterful pivot to recurring services that now form the core of its business.

NATR's Q2 results show a firm investing heavily in its digital future, with soaring e-commerce sales and subscription growth offsetting currency and China woes.

Outset Medical's Q2 results reveal a pivotal moment: a major HCA deal and stronger margins point to a new phase of sustainable growth in the dialysis market.

Stunning 120% revenue growth validates Senseonics' shift to in-house sales, but soaring costs and a widening net loss raise critical questions about its path to profitability.

Doximity's Q1 results reveal a company at a crossroads, sacrificing near-term profits for AI dominance. Engagement is soaring, but financials are strained.

Argentina's top cement firm posts a staggering profit jump, but a deeper analysis reveals operational struggles and a construction sector at a crossroads.

Amphastar beats Q2 estimates with new drug sales, but a deeper look reveals pricing pressure, rising costs, and a high-stakes bet on its pipeline.

A reported net loss obscures core growth at 10x Genomics. An acquisition, key partnerships, and a blockbuster product launch signal a decisive strategic pivot.

After Commerce.com's dismal Q2 results and stock plunge, AI-native rival Rezolve Ai declares its rejected merger proposal was the right path all along.

Where Food Comes From boosts profits via efficiency and new certifications like RaiseWell, offsetting beef market pressures and digital asset swings.

Delcath Systems posts strong revenue and profits, but the real story is its massive investment in expanding its unique liver therapy to fight breast cancer and more.

A shocking $31M loss forces ethical egg purveyor Vital Farms into a defensive crouch, testing if brand loyalty can survive a brutal market oversupply.

Bob's Discount Furniture's impressive Q2 earnings reveal a dual victory: a value proposition resonating with cautious consumers and a massive tariff refund.

Arhaus reported record profits, but a one-time tariff refund tells only half the story. We dig into the numbers to find the real drivers of future growth.

Estonian construction giant Nordecon posts a 37% revenue surge, but shrinking margins reveal the high cost of its pivot to public projects amidst market turmoil.

RECONOVA's massively oversubscribed IPO met a cool reception on its first day, signaling a new era where AI firms must prove profitability, not just potential.

Facing steep losses and a delisting threat, luxury furniture giant Natuzzi is shrinking its Italian footprint and betting on a new generation of leadership.

As Biofrontera preps its Q2 report, investors weigh record revenue and expanded margins against persistent losses and a critical need for cash flow breakeven.

Beyond record revenues, Park-Ohio's Q2 results reveal a strategic pivot, leveraging AI, aerospace, and electrification to forge a less cyclical, high-growth future.